Inhibition of bacterial binding to mouse macrophages by Pseudomonas alginate

Journal of Clinical & Laboratory Immunology
|April 1, 1983
PubMed

Insights

Pseudomonas aeruginosa alginate inhibits bacterial binding to macrophages, potentially aiding mucoid strains in cystic fibrosis lung infections. This suggests alginate provides a survival advantage against immune defenses.

Area of Science:

  • Microbiology
  • Immunology
  • Biochemistry

Background:

  • Mucoid strains of Pseudomonas aeruginosa are prevalent in chronic cystic fibrosis lung infections.
  • Alginate, a polymer produced by mucoid P. aeruginosa, plays a role in bacterial virulence.
  • Bacterial binding to host macrophages is a key step in immune clearance.

Purpose of the Study:

  • To investigate the effect of Pseudomonas aeruginosa alginate on bacterial binding to macrophages.
  • To determine if alginate confers a selective advantage to mucoid P. aeruginosa strains.

Main Methods:

  • Testing the inhibition of isogenic non-mucoid P. aeruginosa revertant binding to mouse macrophages by alginate.
  • Evaluating alginate's effect on the binding of other non-mucoid P. aeruginosa strains and Staphylococcus albus.

Main Results:

  • Alginate significantly inhibited the binding of mucoid P. aeruginosa to mouse peritoneal and pulmonary macrophages.
  • This inhibitory effect was also observed with other non-mucoid P. aeruginosa strains and Staphylococcus albus.

Conclusions:

  • Pseudomonas aeruginosa alginate hinders bacterial adhesion to macrophages.
  • This inhibition may provide mucoid P. aeruginosa with a selective advantage in the lung, contributing to chronic infections in cystic fibrosis patients.